Literature DB >> 23153818

Haploinsufficiency of the autism candidate gene Neurobeachin induces autism-like behaviors and affects cellular and molecular processes of synaptic plasticity in mice.

Kim Nuytens1, Ilse Gantois, Pieter Stijnen, Emilia Iscru, Annelies Laeremans, Lutgarde Serneels, Lien Van Eylen, Stephen A Liebhaber, Koen Devriendt, Detlef Balschun, Lutgarde Arckens, John W M Creemers, Rudi D'Hooge.   

Abstract

Neurobeachin (NBEA), a brain-enriched multidomain scaffolding protein involved in neurotransmitter release and synaptic functioning, has been identified as a candidate gene for autism spectrum disorder (ASD) in four unrelated patients haploinsufficient for NBEA. The aim of this study was to map the behavioral phenotype of Nbea(+/-) mice in order to understand its contribution to the pathogenesis of ASD. ASD-like behavioral variables of Nbea(+/-) mice were related to basal neuronal activity in different brain regions by in situ hybridizations and extracellular field recordings of synaptic plasticity in hippocampal cornu ammonis 1 (CA1) region. Levels of BDNF and phosphorylated cAMP response element-binding protein (CREB) were measured in an attempt to investigate putatively underlying changes in these neuromolecules. Nbea(+/-) mice exhibit several ASD-like features, including changes in self-grooming behavior, social behaviors, conditioned fear responses, and spatial learning and memory, which coincided with enhanced long-term potentiation (LTP) in their CA1 region. The observed alterations in learning and memory and hippocampal LTP are concomitant with decreased expression of the immediate early gene zif268 in dorsomedial striatum and hippocampal CA1 region, increased CREB phosphorylation, and increased hippocampal BDNF expression. These findings indicate that Nbea haploinsufficiency leads to various molecular and cellular changes that affect neuroplasticity and behavioral functions in mice, and could thus underlie the ASD symptomatology in NBEA deficient humans.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153818     DOI: 10.1016/j.nbd.2012.11.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis.

Authors:  Zehra Ordulu; Tammy Kammin; Harrison Brand; Vamsee Pillalamarri; Claire E Redin; Ryan L Collins; Ian Blumenthal; Carrie Hanscom; Shahrin Pereira; India Bradley; Barbara F Crandall; Pamela Gerrol; Mark A Hayden; Naveed Hussain; Bibi Kanengisser-Pines; Sibel Kantarci; Brynn Levy; Michael J Macera; Fabiola Quintero-Rivera; Erica Spiegel; Blair Stevens; Janet E Ulm; Dorothy Warburton; Louise E Wilkins-Haug; Naomi Yachelevich; James F Gusella; Michael E Talkowski; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

2.  NBEA: Developmental disease gene with early generalized epilepsy phenotypes.

Authors:  Maureen S Mulhern; Constance Stumpel; Nicholas Stong; Han G Brunner; Louise Bier; Natalie Lippa; James Riviello; Rob P W Rouhl; Marlies Kempers; Rolph Pfundt; Alexander P A Stegmann; Mary K Kukolich; Aida Telegrafi; Anna Lehman; Elena Lopez-Rangel; Nada Houcinat; Magalie Barth; Nicolette den Hollander; Mariette J V Hoffer; Sarah Weckhuysen; Jolien Roovers; Tania Djemie; Diana Barca; Berten Ceulemans; Dana Craiu; Johannes R Lemke; Christian Korff; Heather C Mefford; Candace T Meyers; Zsuzsanna Siegler; Susan M Hiatt; Gregory M Cooper; E Martina Bebin; Lot Snijders Blok; Hermine E Veenstra-Knol; Evan H Baugh; Eva H Brilstra; Catharina M L Volker-Touw; Ellen van Binsbergen; Anya Revah-Politi; Elaine Pereira; Danielle McBrian; Mathilde Pacault; Bertrand Isidor; Cedric Le Caignec; Brigitte Gilbert-Dussardier; Frederic Bilan; Erin L Heinzen; David B Goldstein; Servi J C Stevens; Tristan T Sands
Journal:  Ann Neurol       Date:  2018-10-25       Impact factor: 10.422

Review 3.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

4.  Genome wide association study identifies variants in NBEA associated with migraine in bipolar disorder.

Authors:  Kaya K Jacobsen; Caroline M Nievergelt; Tetyana Zayats; Tiffany A Greenwood; Verneri Anttila; Hagop S Akiskal; Jan Haavik; Ole Bernt Fasmer; John R Kelsoe; Stefan Johansson; Ketil J Oedegaard
Journal:  J Affect Disord       Date:  2014-10-12       Impact factor: 4.839

5.  Neurobeachin is required postsynaptically for electrical and chemical synapse formation.

Authors:  Adam C Miller; Lisa H Voelker; Arish N Shah; Cecilia B Moens
Journal:  Curr Biol       Date:  2014-12-04       Impact factor: 10.834

6.  Enhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizure.

Authors:  Heather O'Leary; Paul B Bernard; Anna M Castano; Tim A Benke
Journal:  Neurobiol Dis       Date:  2015-12-17       Impact factor: 5.996

Review 7.  Endosomal system genetics and autism spectrum disorders: A literature review.

Authors:  Jameson Patak; Yanli Zhang-James; Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2016-04-02       Impact factor: 8.989

8.  Fragile X Mental Retardation Protein positively regulates PKA anchor Rugose and PKA activity to control actin assembly in learning/memory circuitry.

Authors:  James C Sears; Woong Jae Choi; Kendal Broadie
Journal:  Neurobiol Dis       Date:  2019-02-13       Impact factor: 5.996

9.  Autism-Associated Vigilin Depletion Impairs DNA Damage Repair.

Authors:  Shahid Banday; Raj K Pandita; Arjamand Mushtaq; Albino Bacolla; Ulfat Syed Mir; Dharmendra Kumar Singh; Sadaf Jan; Krishna P Bhat; Clayton R Hunt; Ganesh Rao; Vijay K Charaka; John A Tainer; Tej K Pandita; Mohammad Altaf
Journal:  Mol Cell Biol       Date:  2021-06-23       Impact factor: 4.272

10.  Neurobeachin, a promising target for use in the treatment of alcohol use disorder.

Authors:  Verginia C Cuzon Carlson; Carlos F Aylwin; Timothy L Carlson; Matthew Ford; Houda Mesnaoui; Alejandro Lomniczi; Betsy Ferguson; Rita P Cervera-Juanes
Journal:  Addict Biol       Date:  2021-10-26       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.